BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12186261)

  • 1. Eculizumab (Alexion).
    Kaplan M
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1017-23. PubMed ID: 12186261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pexelizumab Alexion.
    Whiss PA
    Curr Opin Investig Drugs; 2002 Jun; 3(6):870-7. PubMed ID: 12137406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept. Immunex.
    Pugsley MK
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1725-31. PubMed ID: 11892935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valdecoxib (Pharmacia).
    Gotta AW
    Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exubera. Inhale therapeutic systems.
    Bindra S; Cefalu WT
    Curr Opin Investig Drugs; 2002 May; 3(5):758-62. PubMed ID: 12090549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technology evaluation: adalimumab, Abbott laboratories.
    Lorenz HM
    Curr Opin Mol Ther; 2002 Apr; 4(2):185-90. PubMed ID: 12044041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IDEC-131. IDEC/Eisai.
    Dumont FJ
    Curr Opin Investig Drugs; 2002 May; 3(5):725-34. PubMed ID: 12090546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus. Novartis.
    Schopf RE
    Curr Opin Investig Drugs; 2002 May; 3(5):720-4. PubMed ID: 12090545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GL-701 Genelabs.
    Norman P
    Curr Opin Investig Drugs; 2001 Feb; 2(2):231-6. PubMed ID: 11816836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oprelvekin. Genetics Institute.
    Sitaraman SV; Gewirtz AT
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1395-400. PubMed ID: 11890354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuvion. Protein Design Labs.
    Trajkovic V
    Curr Opin Investig Drugs; 2002 Mar; 3(3):411-4. PubMed ID: 12054088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iloperidone (Novartis).
    Hesselink JM
    IDrugs; 2002 Jan; 5(1):84-90. PubMed ID: 12861482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tegaserod (Novartis).
    Norman P
    IDrugs; 2002 Feb; 5(2):171-9. PubMed ID: 12861478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abetimus (La Jolla pharmaceuticals).
    Lorenz HM
    Curr Opin Investig Drugs; 2002 Feb; 3(2):234-9. PubMed ID: 12020052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanamivir (Glaxo Wellcome).
    Oxford JS
    IDrugs; 2000 Apr; 3(4):447-59. PubMed ID: 16100701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCI-779 Wyeth.
    Elit L
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1249-53. PubMed ID: 12211424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-0991 (Merck & Co).
    Groll AH; Walsh TJ
    IDrugs; 1999 Nov; 2(11):1201-12. PubMed ID: 16113992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MethyPatch Noven.
    Sane N; McGough JJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1222-4. PubMed ID: 12211419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cladribine. Ortho Biotech Inc.
    Tortorella C; Rovaris M; Filippi M
    Curr Opin Investig Drugs; 2001 Dec; 2(12):1751-6. PubMed ID: 11892941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conivaptan (Yamanouchi).
    Martinez-Castelao A
    Curr Opin Investig Drugs; 2002 Jan; 3(1):89-95. PubMed ID: 12054079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.